The Prescription | June 2022

• When is a patent licence not a licence to exploit the invention? The High Court answers a $26 million question

  By

  • Ben Miller
  • & Jenny Wong

  We analyse the High Court’s decision on patent licences in settlement agreements in H Lundbeck A/S v Sandoz Pty Ltd [2022] HCA 4.

• Patent term extension update: first in, best dressed; too late for the rest

  By

  • Ben Miller,
  • Stephen Rohl

  We discuss two decisive judgments of the Full Federal Court on patent term extensions, and the implications for existing extensions.

• Interlocutory injunction denied because of a questionable term extension

  By

  • Ben Miller,
  • Stephen Rohl
  • & Jenny Wong

  We consider the decision in Biogen International GmbH v Pharmacor Pty Ltd [2021] FCA 1591.

• It's about time the Australian Patent Office required more precision

  By

  • Ben Miller
  • & Jenny Wong

  We discuss the difficulties that can arise from the use of terms of approximation (e.g. “about”) in patent claims.

• Broad Institute triumphs in CRISPR priority challenge

  By

  • Ben Miller
  • & Jenny Wong

  We provide an update on the US patent interferences regarding the revolutionary CRISPR genome-editing technology.

• Cosmetic medical and surgical procedures: Regulation and patient safety

  By

  • Angela Wood,
  • Tamie Duncan-Bible
  • & Nina Prica

  We provide an update on the Independent Review of the Regulation of Health Practitioners and Patient Safety Issues in Cosmetic Surgery by AHPRA and Medical Board of Australia.

• Former Minister Hunt’s final address at the Australian Pharmacy Professional Conference 2022 and PBS changes

  By

  • Damien Wurzel,
  • Steven Tang

  We discuss former Minister Greg Hunt’s address at this year’s APP Conference.